Bluejay Diagnostics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 9.95 million compared to USD 9.3 million a year ago. Basic loss per share from continuing operations was USD 9.08 compared to USD 9.22 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.51 USD | +11.62% |
|
+17.78% | -58.20% |
05-31 | Bluejay Diagnostics, Inc. announced a financing transaction | CI |
05-15 | Bluejay Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-58.20% | 1.48M | |
+11.68% | 3.7B | |
+0.37% | 2.28B | |
-21.21% | 1.99B | |
-23.77% | 1.6B | |
+14.81% | 999M | |
+18.25% | 739M | |
-10.04% | 687M | |
-36.12% | 461M | |
-4.47% | 279M |
- Stock Market
- Equities
- BJDX Stock
- News Bluejay Diagnostics, Inc.
- Bluejay Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023